An observational study in Endocrine Procedural Complications, Thyroid and Parathyroid; Deficiency, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Central Hospital, Nancy, France · Observational
The goal of this study is to evaluate the role of intraoperative continous and intermittent neuromonitoring and intraoperative parathormone (PTH) to predict postoperative nerve morbidity and hypocalcemia.
Intraoperative PTH values and intraoperative continuous neuromonitoring will be collected prospectively in consecutive patients who undergo total thyroidectomy.
Postoperative parathyroid morbidity and recurrent laryngeal nerve morbidity will be evaluated within 1 week after total thyroidectomy and at 1 year postoperatively.
Other postoperative morbidity will be evaluated at 1 year postoperatively using validated classification.
365 studies on the registry are indexed under Thyroid Diseases; 80 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 198 across 158 observational studies indexed under Thyroid Diseases.
Browse Thyroid Diseases studies →Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients scheduled for total thyroidectomy in university of Nancy (University Hospital)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
intraoperative parathormone values
parathormone in pg/mL
Time frame: intraoperative
postoperative hypocalcemia
calcium in mg/L
Time frame: within 1 week after thyroidectomy
postoperative hypoparathyroidism
parathormone in pg/mL
Time frame: within 1 week after thyroidectomy
permanent postoperative hypocalcemia
calcium in mg/L
Time frame: at one year after thyroidectomy
permanent postoperative hypoparathyroidism
parathormone in pg/mL
Time frame: at one year after thyroidectomy
laryngeal nerve palsy
continuous intraoperative neuromonitoring (\> 50% baseline values yes/no)
Time frame: during thyroidectomy
laryngeal nerve palsy
laryngoscopy (normal / palsy)
Time frame: within 1 week after thyroidectomy
laryngeal nerve palsy
laryngoscopy (normal / palsy)
Time frame: at one year after thyroidectomy
Postoperative complications other than outcomes from 1 to 8
Postoperative morbidity classification (using a Clavien-Dindo classification) postoperatively
Time frame: at one year after thyroidectomy
The record gives a start of Mar 2016, a primary completion of Oct 2026 and a completion of Oct 2026. It does not say whether these dates are actual or estimated.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 20, 2026: primary completion Mar 2026 → Oct 2026 and completion Mar 2026 → Oct 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →